Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences

Rhea-AI Summary

Alpine Immune Sciences (ALPN) to participate in two healthcare conferences to discuss IgA Nephropathy and biopharma developments. Live webcasts and investor meetings scheduled.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences.

• Monday, March 4^th, Mitchell Gold, M.D., Executive Chairman and Chief Executive Officer will participate in an IgA Nephropathy corporate panel at 9:10 am ET/6:10 am PT during the TD Cowen 44th Annual Healthcare Conference in Boston, MA and the Company will host investor meetings the same day.
• Tuesday, March 12^th, Remy Durand, Ph.D., Chief Business Officer will participate in a fireside chat during the Leerink Partners Global Biopharma Conference in Miami, FL at 2:20 pm ET/11:20 am PT and the Company will host investor meetings the same day.

Live webcasts of the fireside chats will be available in the investor relations section of the Company’s website at https://ir.alpineimmunesciences.com/events and a replay will be available on the Company's website for 90 days following the event.

About Alpine Immune Sciences

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on X and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240226284227/en/

Media and Investor Relations Contact:

ir@alpineimmunesciences.com

media@alpineimmunesciences.com

Source: Alpine Immune Sciences, Inc.

When will Alpine Immune Sciences (ALPN) participate in the IgA Nephropathy corporate panel?

Alpine Immune Sciences will participate in the IgA Nephropathy corporate panel on Monday, March 4th at 9:10 am ET/6:10 am PT during the TD Cowen 44th Annual Healthcare Conference in Boston, MA.

Who will participate in the fireside chat during the Leerink Partners Global Biopharma Conference?

Remy Durand, Ph.D., Chief Business Officer of Alpine Immune Sciences, will participate in the fireside chat during the Leerink Partners Global Biopharma Conference on Tuesday, March 12th at 2:20 pm ET/11:20 am PT in Miami, FL.

Where can investors watch the live webcasts of the fireside chats?

Investors can watch the live webcasts of the fireside chats on the investor relations section of Alpine Immune Sciences' website at https://ir.alpineimmunesciences.com/events.

For how long will the replay of the webcasts be available?

The replay of the webcasts will be available on Alpine Immune Sciences' website for 90 days following the event.